Changing Agendas on Sleep, Treatment and Learning in Epilepsy (CASTLE) Sleep-E: a protocol for a randomised controlled trial comparing an online behavioural sleep intervention with standard care in children with Rolandic epilepsy.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
10 03 2023
Historique:
entrez: 10 3 2023
pubmed: 11 3 2023
medline: 15 3 2023
Statut: epublish

Résumé

Sleep and epilepsy have an established bidirectional relationship yet only one randomised controlled clinical trial has assessed the effectiveness of behavioural sleep interventions for children with epilepsy. The intervention was successful, but was delivered via face-to-face educational sessions with parents, which are costly and non-scalable to population level. The Changing Agendas on Sleep, Treatment and Learning in Epilepsy (CASTLE) Sleep-E trial addresses this problem by comparing clinical and cost-effectiveness in children with Rolandic epilepsy between standard care (SC) and SC augmented with a novel, tailored parent-led CASTLE Online Sleep Intervention (COSI) that incorporates evidence-based behavioural components. CASTLE Sleep-E is a UK-based, multicentre, open-label, active concurrent control, randomised, parallel-group, pragmatic superiority trial. A total of 110 children with Rolandic epilepsy will be recruited in outpatient clinics and allocated 1:1 to SC or SC augmented with COSI (SC+COSI). Primary clinical outcome is parent-reported sleep problem score (Children's Sleep Habits Questionnaire). Primary health economic outcome is the incremental cost-effectiveness ratio (National Health Service and Personal Social Services perspective, Child Health Utility 9D Instrument). Parents and children (≥7 years) can opt into qualitative interviews and activities to share their experiences and perceptions of trial participation and managing sleep with Rolandic epilepsy. The CASTLE Sleep-E protocol was approved by the Health Research Authority East Midlands (HRA)-Nottingham 1 Research Ethics Committee (reference: 21/EM/0205). Trial results will be disseminated to scientific audiences, families, professional groups, managers, commissioners and policymakers. Pseudo-anonymised individual patient data will be made available after dissemination on reasonable request. ISRCTN13202325.

Identifiants

pubmed: 36898757
pii: bmjopen-2022-065769
doi: 10.1136/bmjopen-2022-065769
pmc: PMC10008377
doi:

Types de publication

Clinical Trial Protocol Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e065769

Informations de copyright

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Front Comput Neurosci. 2021 Jun 18;15:680549
pubmed: 34220477
Health Qual Life Outcomes. 2011 Dec 30;9:119
pubmed: 22208861
Epilepsia. 2012 Jul;53(7):1162-9
pubmed: 22594377
Sleep. 2000 Dec 15;23(8):1043-51
pubmed: 11145319
Trials. 2017 Nov 28;18(1):572
pubmed: 29183384
Sleep Med Rev. 2021 Jun;57:101466
pubmed: 33838598
Acta Psychiatr Scand. 1983 Jun;67(6):361-70
pubmed: 6880820
J Am Acad Child Adolesc Psychiatry. 2001 Nov;40(11):1337-45
pubmed: 11699809
J Pharmacol Pharmacother. 2010 Jul;1(2):100-7
pubmed: 21350618
Health Econ. 2001 Dec;10(8):779-87
pubmed: 11747057
Psychosom Med. 2011 May;73(4):323-35
pubmed: 21536837
BMJ. 2019 Nov 11;367:l6096
pubmed: 31712327
Pharmacoeconomics. 2019 Apr;37(4):475-499
pubmed: 30887469
Front Psychol. 2021 Jul 29;12:628605
pubmed: 34393875
Health Econ. 2022 Jun;31(6):923-939
pubmed: 35229404
Front Psychol. 2018 Mar 07;9:241
pubmed: 29563887
Arch Dis Child. 2020 Jun;105(6):569-574
pubmed: 31937568
Pediatrics. 2020 Jul;146(1):
pubmed: 32554521
Front Psychol. 2021 Jul 02;12:679804
pubmed: 34276499
J Clin Epidemiol. 2017 Oct;90:92-98
pubmed: 28694123
BMC Med Res Methodol. 2017 Dec 6;17(1):162
pubmed: 29207961
Appl Health Econ Health Policy. 2005;4(2):65-75
pubmed: 16162026
Sleep. 2020 Jan 13;43(1):
pubmed: 31552428
Control Clin Trials. 1989 Dec;10(4):407-15
pubmed: 2691207
Epilepsia. 2003 Apr;44(4):598-612
pubmed: 12681011
Epilepsy Behav. 2020 Nov;112:107371
pubmed: 32861897
Arch Dis Child. 2019 Feb;104(2):189-192
pubmed: 30266875
Lancet Neurol. 2019 Apr;18(4):357-375
pubmed: 30773428
Sleep Med Rev. 2021 Apr;56:101412
pubmed: 33422935
Sleep. 2011 May 01;34(5):601-8
pubmed: 21532953
BMJ. 2017 Aug 2;358:j3453
pubmed: 28768629
Epilepsy Behav. 2020 Feb;103(Pt A):106437
pubmed: 31645314
BMJ. 2013 Jan 08;346:e7586
pubmed: 23303884
Gen Hosp Psychiatry. 2012 May-Jun;34(3):234-41
pubmed: 22325631
Epilepsia. 2019 May;60(5):857-871
pubmed: 31021436
BMJ. 2013 Mar 25;346:f1049
pubmed: 23529982
Pharmacoeconomics. 2012 Aug 1;30(8):729-47
pubmed: 22788262
Ann Intern Med. 2013 Feb 5;158(3):200-7
pubmed: 23295957
Trials. 2017 Jun 20;18(Suppl 3):280
pubmed: 28681707
Sleep. 2020 Feb 13;43(2):
pubmed: 31608389
Sleep Med. 2014 Sep;15(9):1075-81
pubmed: 24974198
Qual Life Res. 2010 Aug;19(6):875-86
pubmed: 20405245
Sleep. 2020 Sep 14;43(9):
pubmed: 32163581
BMJ Open. 2021 Jun 30;11(6):e045105
pubmed: 34193486
Proc Am Thorac Soc. 2007 Oct 1;4(7):577-82
pubmed: 17878473
JAMA Otolaryngol Head Neck Surg. 2020 Feb 1;146(2):101-102
pubmed: 31804662
BMJ. 2011 Apr 07;342:d1548
pubmed: 21474510

Auteurs

Nadia Al-Najjar (N)

Liverpool Clinical Trials Centre, Institute of Population Health, Faculty of Health and Life Sciences, University of Liverpool, Liverpool, UK.

Lucy Bray (L)

Department of Nursing & Midwifery, Faculty of Health, Social Care and Medicine, Edge Hill University, Ormskirk, UK.

Bernie Carter (B)

Department of Nursing & Midwifery, Faculty of Health, Social Care and Medicine, Edge Hill University, Ormskirk, UK.

Advisory Panel Castle (AP)

Department of Nursing & Midwifery, Faculty of Health, Social Care and Medicine, Edge Hill University, Ormskirk, UK.

Amber Collingwood (A)

Department of Basic and Clinical Neurosciences, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.

Georgia Cook (G)

Centre for Psychological Research, Faculty of Health and Life Sciences, Oxford Brookes University, Oxford, UK.

Holly Crudgington (H)

Department of Basic and Clinical Neurosciences, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.

Janet Currier (J)

Department of Nursing & Midwifery, Faculty of Health, Social Care and Medicine, Edge Hill University, Ormskirk, UK.

Kristina Charlotte Dietz (KC)

Department of Basic and Clinical Neurosciences, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK kristina.dietz@kcl.ac.uk.

Will A S Hardy (WAS)

Centre for Health Economics and Medicines Evaluation, School of Medical and Health Sciences, Bangor University, Bangor, UK.

Harriet Hiscock (H)

Centre for Community Child Health, Murdoch Children's Research Institute, Parkville, Victoria, Australia.

Dyfrig Hughes (D)

Centre for Health Economics and Medicines Evaluation, School of Medical and Health Sciences, Bangor University, Bangor, UK.

Christopher Morris (C)

University of Exeter Medical School, Faculty of Health and Life Sciences, University of Exeter, Exeter, UK.

Deborah Roberts (D)

Department of Nursing & Midwifery, Faculty of Health, Social Care and Medicine, Edge Hill University, Ormskirk, UK.

Alison Rouncefield-Swales (A)

Department of Nursing & Midwifery, Faculty of Health, Social Care and Medicine, Edge Hill University, Ormskirk, UK.

Holly Saron (H)

Department of Nursing & Midwifery, Faculty of Health, Social Care and Medicine, Edge Hill University, Ormskirk, UK.

Catherine Spowart (C)

Liverpool Clinical Trials Centre, Institute of Population Health, Faculty of Health and Life Sciences, University of Liverpool, Liverpool, UK.

Lucy Stibbs-Eaton (L)

Liverpool Clinical Trials Centre, Institute of Population Health, Faculty of Health and Life Sciences, University of Liverpool, Liverpool, UK.

Catrin Tudur Smith (C)

Department of Health Data Science, Institute of Population Health, Faculty of Health and Life Sciences, University of Liverpool, Liverpool, UK.

Victoria Watson (V)

Department of Health Data Science, Institute of Population Health, Faculty of Health and Life Sciences, University of Liverpool, Liverpool, UK.

Liam Whittle (L)

Department of Health Data Science, Institute of Population Health, Faculty of Health and Life Sciences, University of Liverpool, Liverpool, UK.

Luci Wiggs (L)

Centre for Psychological Research, Faculty of Health and Life Sciences, Oxford Brookes University, Oxford, UK.

Eifiona Wood (E)

Centre for Health Economics and Medicines Evaluation, School of Medical and Health Sciences, Bangor University, Bangor, UK.

Paul Gringras (P)

Department of Sleep Medicine, Evelina London Children's Hospital, London, UK.

Deb K Pal (DK)

Department of Basic and Clinical Neurosciences, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH